Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inland Laboratories is a specialized biotechnology company focused on the extraction, purification, and distribution of biological toxins and venoms. The company serves as a premier supplier of high-quality snake, scorpion, and spider venoms to global research institutions and pharmaceutical corporations. These materials are essential for drug discovery efforts, particularly in developing treatments for cardiovascular diseases, neurological disorders, and chronic pain. In addition to raw venom, Inland Laboratories provides purified toxins and custom biological fractions to meet specific research requirements. By maintaining a diverse serpentarium and specialized laboratory facilities, the company ensures a consistent supply of rare biological reagents for the life sciences community. Their products have been instrumental in the development of various diagnostic tools and venom-derived therapeutic candidates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inland Laboratories.